RECIPIENT
:
SPEAKER
(S):
Paul Ness, MD, Director, Transfusion Medicine, Johns Hopkins Medical Institutions
Christine Lomas-Francis, MSc, FIBMS, Technical Director, New York Blood Center
Patricia Arndt, MS, MT(ASCP)SBB, Senior Research Associate, American Red Cross
Description
Immune hemolytic anemias (IHA) may be categorized as alloimmune, autoimmune and drug-induced. This session will review key concepts for the diagnosis, classification and serology of autoimmune hemolytic anemia and drug-induced immune hemolytic anemia. Case studies will supplement the theoretical review to illustrate typical serology. Equipped with academic knowledge and serologic characteristics of these sometimes difficult-to-recognize IHAs, attendees will be able to compare and contrast autoimmune hemolytic anemia and drug-induced immune hemolytic anemia in order to expedite recognition and subsequent resolution for their patients.
LEARNER OUTCOMES:
-
Describe the diagnosis, treatment and transfusion support in the major types of autoimmune hemolytic anemia.
-
Discover techniques for the selection of blood products for patients with autoimmune hemolytic anemia.
-
Discuss the diagnosis and classification of drug-induced immune hemolytic anemia.
-
Explain and compare the key serologic features of the most common types of autoimmune and drug-induced immune hemolytic anemia.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
2.5 |
California Nurse |
3 |
Florida Laboratory Personnel |
3 |
General Attendee |
2.5 |
Physician |
2.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.